Near Infrared Imaging/NIR Market - Industry Share Analysis, Key Players and Future Prospect| Biospace Lab (France), Fluoptics (France), Mizuho Corporation (Japan), Li-Cor, Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss Meditec AG (Germany), Novadaq Te

The Research Report on "Near Infrared Imaging/NIR Market by Product (Fluorescence Imaging, Reagents), Application (Preclinical, Clinical, Medical), Procedure (Cancer, GIT, Plastic surgery), Enduser (Hospital, Clinics, Researchers, Pharma-biotech) (2022 - 2026)", is expected to grow from an estimated USD 0.8 billion in 2021 to USD 1.6 billion by 2026, at a CAGR of 14.0%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174869738&utm_source=OPenpr&utm_medium=Paid&utm_campaign=Referral

Growing number of surgical procedures globally;

Globally, the number of surgical procedures is on the rise owing to the rising prevalence and incidence of various diseases such as cancer, cardiovascular diseases, neurovascular diseases, and gastrointestinal diseases. Surgical cosmetic procedures and trauma cases are also contributing to the increasing number of surgical procedures. NIR imaging is used for intraoperative imaging during various surgical procedures, such as plastic and reconstructive surgeries, oncology surgeries, gastrointestinal surgeries, cardiovascular surgeries, cardiothoracic surgeries, and neurovascular surgeries. NIR imaging enables surgeons to assess blood flow, tissue viability, and perfusion during these surgeries. In cancer surgeries, NIR imaging is used to establish positive margins that help in the demarcation of cancerous tissues versus normal tissues. Therefore, the increasing number of surgical procedures is expected to drive the NIR imaging market.

Industry Segmentation In Detailed:

The near-infrared imaging devices is estimated to account for the largest share of the global near-infrared imaging market during the forecast period.

On the basis of product, devices and probe/dye. The devices product segment, by type, is further segmented into near-infrared fluorescence imaging systems and near-infrared fluorescence and bioluminescence imaging systems. The near-infrared fluorescence imaging systems segment is estimated to account for the largest share of the near-infrared imaging market, by product, in 2021, driven by growing research activities, advantages offered by near-infrared fluorescence imaging systems such as high sensitivity, high image resolution, and real-time image guidance during surgeries, the rising prevalence of cancer, cardiovascular diseases, and gastrointestinal diseases.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174869738&utm_source=OPenpr&utm_medium=Paid&utm_campaign=Referral

The preclinical imaging segment is estimated to account for the largest share of the global near-infrared imaging market during the forecast period.

On the basis of application, the near-infrared imaging market is segmented into preclinical imaging, clinical imaging, medical imaging. The preclinical imaging segment is estimated to account for the largest share of the global near-infrared imaging market, by application, in 2021, led by The growing focus on developing new treatments for diseases/conditions such as cancer, inflammation, angiogenesis, infections, and vascular diseases.

Leading Key Players and Analysis:

The major players in the near-infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Medtronic (US), Hamamatsu Photonics K.K. (Japan), Shimadzu Corporation (Japan), Mizuho Medical Co., Ltd. (Japan), Fluoptics (France), Quest Medical Imaging B.V. (Netherlands), Sigma-Aldrich (Germany), and Teledyne Princeton Instruments (US), among others.

Geographical Analysis in Detailed:

North America accounted for the largest market share in the near-infrared imaging market in 2020. The near-infrared imaging market in North America is driven primarily by factors such as the high healthcare spending, rising geriatric population, the rising prevalence of target diseases, growing number of cosmetic surgeries, ongoing research activities, and rapid adoption of technologically advanced imaging systems.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=174869738&utm_source=OPenpr&utm_medium=Paid&utm_campaign=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.